Sestamibi MBI If a benign entity has been found on US and is the definitive correlate for a palpable mass, there is no evidence for Tc-99m sestamibi MBI in women <30 years of age. Palpable Breast Masses age, if physical examination is highly suspicious and DBT and US are negative, tissue sampling with core biopsy or surgical biopsy is warranted. Digital Breast Tomosynthesis Screening In women presenting with signs or symptoms, including a palpable breast mass, screening DBT, with or without DM, is not useful as the next imaging study. Screening mammography is provided to women without signs or symptoms of breast disease. FDG-PET Breast Dedicated There is no relevant literature to support the use of the use of FDG-PET breast dedicated in women <30 years of age with negative US findings [2]. Image-Guided Core Biopsy Breast There is no relevant literature to support the use of the use of image-guided core biopsy in women <30 years of age with negative US findings. Image-Guided Fine Needle Aspiration Breast There is no relevant literature to support the use of the use of image-guided FNAB in women <30 years of age with negative US findings. Mammography Screening In women presenting with signs or symptoms, including a palpable breast mass, screening mammography is not useful as the next imaging study. Screening mammography is provided to women without signs or symptoms of breast disease. MRI Breast There is no relevant literature to support the use of the use of MRI of the breast with or without IV contrast in women in women <30 years of age with negative US findings [2,23-25]. Sestamibi MBI There is no relevant literature to support the use of the use of Tc-99m sestamibi MBI in women <30 years of age with negative US findings. Digital Breast Tomosynthesis Screening In women presenting with signs or symptoms, including a palpable breast mass, screening DBT, with or without DM, is not useful as the initial imaging study.
Palpable Breast Masses. Sestamibi MBI If a benign entity has been found on US and is the definitive correlate for a palpable mass, there is no evidence for Tc-99m sestamibi MBI in women <30 years of age. Palpable Breast Masses age, if physical examination is highly suspicious and DBT and US are negative, tissue sampling with core biopsy or surgical biopsy is warranted. Digital Breast Tomosynthesis Screening In women presenting with signs or symptoms, including a palpable breast mass, screening DBT, with or without DM, is not useful as the next imaging study. Screening mammography is provided to women without signs or symptoms of breast disease. FDG-PET Breast Dedicated There is no relevant literature to support the use of the use of FDG-PET breast dedicated in women <30 years of age with negative US findings [2]. Image-Guided Core Biopsy Breast There is no relevant literature to support the use of the use of image-guided core biopsy in women <30 years of age with negative US findings. Image-Guided Fine Needle Aspiration Breast There is no relevant literature to support the use of the use of image-guided FNAB in women <30 years of age with negative US findings. Mammography Screening In women presenting with signs or symptoms, including a palpable breast mass, screening mammography is not useful as the next imaging study. Screening mammography is provided to women without signs or symptoms of breast disease. MRI Breast There is no relevant literature to support the use of the use of MRI of the breast with or without IV contrast in women in women <30 years of age with negative US findings [2,23-25]. Sestamibi MBI There is no relevant literature to support the use of the use of Tc-99m sestamibi MBI in women <30 years of age with negative US findings. Digital Breast Tomosynthesis Screening In women presenting with signs or symptoms, including a palpable breast mass, screening DBT, with or without DM, is not useful as the initial imaging study.